Vibozilimod (SCD-044) is a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist. This small molecule is utilized in research to investigate S1PR1-mediated pathways in immunology and inflammation, with applications in both in vitro cellular assays and in vivo disease models.